106 related articles for article (PubMed ID: 6689141)
1. Amsacrine cardiotoxicity: assessment of ventricular function by radionuclide angiography.
Vorobiof DA; Iturralde M; Falkson G
Cancer Treat Rep; 1983 Dec; 67(12):1115-7. PubMed ID: 6689141
[TBL] [Abstract][Full Text] [Related]
2. Amsacrine-associated cardiotoxicity: an analysis of 82 cases.
Weiss RB; Grillo-López AJ; Marsoni S; Posada JG; Hess F; Ross BJ
J Clin Oncol; 1986 Jun; 4(6):918-28. PubMed ID: 3519882
[TBL] [Abstract][Full Text] [Related]
3. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance.
Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL
Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of m-AMSA in patients with malignant mesothelioma.
Falkson G; Vorobiof DA; Lerner HJ
Cancer Chemother Pharmacol; 1983; 11(2):94-7. PubMed ID: 6688764
[TBL] [Abstract][Full Text] [Related]
5. Assessment of ventricular function by radionuclide angiography in patients receiving 4'-epidoxorubicin and mitoxantrone.
Vorobiof DA; Iturralde M; Falkson G
Cancer Chemother Pharmacol; 1985; 15(3):253-7. PubMed ID: 3863718
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of left ventricular function using radionuclide scans in patients receiving mitoxantrone.
Aapro MS; Alberts DS; Woolfenden JM; Mackel C
Invest New Drugs; 1983; 1(4):341-7. PubMed ID: 6678882
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity reactions to amsacrine.
Perry DJ; Weiss RB; Hoth DF
Cancer Treat Rep; 1985 Feb; 69(2):199-201. PubMed ID: 3155993
[TBL] [Abstract][Full Text] [Related]
8. Acute myocardial necrosis during administration of amsacrine.
Lindpaintner K; Lindpaintner LS; Wentworth M; Burns CP
Cancer; 1986 Apr; 57(7):1284-6. PubMed ID: 3753891
[TBL] [Abstract][Full Text] [Related]
9. QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine.
Schwartz CL; Bender KS; Burke PJ; Kan JS; Civin CI
Cancer Treat Rep; 1984; 68(7-8):1043-4. PubMed ID: 6547639
[No Abstract] [Full Text] [Related]
10. Acute ECG changes associated with AMSA treatment.
Miller CF; Rajdev N
Cancer Treat Rep; 1982 Aug; 66(8):1678-80. PubMed ID: 6896676
[No Abstract] [Full Text] [Related]
11. Effects of amsacrine (m-AMSA), a new aminoacridine antitumor drug, on the rabbit heart.
D'Alessandro N; Gebbia N; Crescimanno M; Flandina C; Leto G; Tumminello FM; Messina L
Cancer Treat Rep; 1983 May; 67(5):467-74. PubMed ID: 6687838
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study.
Amrein PC; Coleman M; Richards F; Poulin RF; Berkowitz I; Kennedy BJ; Green M; Herschkopf R; Rafla S
Cancer Treat Rep; 1983 Nov; 67(11):1043-4. PubMed ID: 6688967
[No Abstract] [Full Text] [Related]
13. Cardiac abnormalities after AMSA administration.
Steinherz LJ; Steinherz PG; Mangiacasale D; Tan C; Miller DR
Cancer Treat Rep; 1982 Mar; 66(3):483-8. PubMed ID: 6949643
[TBL] [Abstract][Full Text] [Related]
14. Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).
Falkson G
Cancer Treat Rep; 1980; 64(2-3):358. PubMed ID: 6157470
[No Abstract] [Full Text] [Related]
15. Evaluation of ventricular function by echocardiography and radionuclide angiography in patients treated with mitoxantrone.
Villani F; Galimberti M; Crippa F
Drugs Exp Clin Res; 1989; 15(10):501-6. PubMed ID: 2632218
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of AMSA in patients with metastatic lung cancer.
Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Ryan DH
Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
[No Abstract] [Full Text] [Related]
19. Amsacrine in refractory acute leukemia.
Griffin JD; Maguire ME; Mayer RJ
Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
